Intensity Therapeutics (INTS) Cash & Current Investments (2022 - 2026)
Intensity Therapeutics' Cash & Current Investments came in at $9.53 million for Q2 2026, up 330.0% from $2.22 million a year earlier but down 7.0% from the prior quarter.
Powered by 
Analysis
Intensity Therapeutics (INTS) Cash & Current Investments (2022 - 2026) Analysis & Trends
At the end of FY2025, Intensity Therapeutics' Cash & Current Investments was $11.92 million, up 360.3% from FY2024.
- Cash & Current Investments carries a three-year compound annual growth rate of 108.7% (FY2022 to FY2025).
- Going back by year, Cash & Current Investments was $2.59 million in FY2024 (-82.5%), $14.78 million in FY2023 and $1.31 million in FY2022.
- The five-year range for quarterly Cash & Current Investments is $135,765 (Q2 2023) to $15.65 million (Q3 2023).
- Year-over-year, Cash & Current Investments increased in three of the last seven quarters, with growth averaging 74.6%.
- The fastest year-over-year change in Cash & Current Investments over five years came in Q4 2025 (growth of 360.3%), and the weakest in Q1 2025 (a decline of 91.1%).
- Business Quant data shows INTS's Cash & Current Investments at $10.25 million (Q1 2026), $11.92 million (Q4 2025) and $7.07 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,163.48 Bn | 1,132.06 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 631.16 Bn | 549.69 Bn | 17.26 Bn | 20.76 Bn |
| 3 | AbbVie | 502.63 Bn | 475.74 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 378.53 Bn | 332.91 Bn | 12.21 Bn | 7.14 Bn |
| 5 | Novartis Ag | 302.83 Bn | 266.82 Bn | 11.24 Bn | 7.69 Bn |
| 6 | Astrazeneca | 265.92 Bn | 239.60 Bn | 12.86 Bn | 4.90 Bn |
| 7 | Amgen | 240.87 Bn | 196.27 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 194.04 Bn | 168.24 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 172.14 Bn | 118.78 Bn | 10.94 Bn | 11.70 Bn |
| 10 | Intensity Therapeutics | 8.82 Mn | -29.94 Mn | - | 9.53 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 9.53 Mn |
| Mar 31, 2026 | 10.25 Mn |
| Dec 31, 2025 | 11.92 Mn |
| Sep 30, 2025 | 7.07 Mn |
| Jun 30, 2025 | 2.22 Mn |
| Mar 31, 2025 | 929,000.00 |
| Dec 31, 2024 | 2.59 Mn |
| Sep 30, 2024 | 2.80 Mn |
| Jun 30, 2024 | 6.34 Mn |
| Mar 31, 2024 | 10.50 Mn |
| Dec 31, 2023 | 14.78 Mn |
| Sep 30, 2023 | 15.65 Mn |
| Jun 30, 2023 | 135,765.00 |
| Mar 31, 2023 | 8.56 Mn |
| Dec 31, 2022 | 1.31 Mn |
API Access
Intensity Therapeutics Cash & Current Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=INTS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-current-investments", "ticker": "INTS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=INTS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();